TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -229.73%-497.41M | ---- | -71.28%383.43M | ---- | 200.38%1.34B | ---- | -66.04%444.49M | ---- | 77.42%1.31B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -23.59%-351.1M | ---- | -17.67%-284.09M | ---- | 29.08%-241.44M | ---- | -8.36%-340.44M | ---- | -24.19%-314.18M |
Dividend (income)- adjustment | ---- | 0.82%-20.59M | ---- | 22.68%-20.76M | ---- | 55.08%-26.84M | ---- | -182.91%-59.76M | ---- | -68.70%-21.12M |
Attributable subsidiary (profit) loss | ---- | 100.98%1.87M | ---- | -103.98%-190.2M | ---- | 62.19%-93.25M | ---- | 38.73%-246.6M | ---- | -1,870.76%-402.47M |
Impairment and provisions: | ---- | 6,003.70%679.77M | ---- | -94.83%11.14M | ---- | 763.47%215.35M | ---- | -109.40%-32.46M | ---- | 1,103.92%345.43M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -109.38%-32.46M | ---- | 3,158.48%345.85M |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---424K |
-Other impairments and provisions | ---- | 6,003.70%679.77M | ---- | -94.83%11.14M | ---- | --215.35M | ---- | ---- | ---- | ---- |
Revaluation surplus: | ---- | 654.96%162.38M | ---- | 95.88%-29.26M | ---- | -3,525.87%-710.34M | ---- | -106.64%-19.59M | ---- | 1,297.71%294.85M |
-Fair value of investment properties (increase) | ---- | --36.07M | ---- | ---- | ---- | ---1.28B | ---- | ---- | ---- | ---- |
-Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | ---- | -273.15%-107.47M | ---- | 68.28%62.06M | ---- | --36.88M |
-Other fair value changes | ---- | 531.69%126.31M | ---- | -104.31%-29.26M | ---- | 930.82%678.41M | ---- | -131.65%-81.66M | ---- | 1,122.88%257.97M |
Asset sale loss (gain): | ---- | 75.76%-40.98M | ---- | 77.23%-169.05M | ---- | -2,381.82%-742.44M | ---- | -3,465.55%-29.92M | ---- | -4,295.00%-839K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | 78.01%-163.27M | ---- | -2,381.82%-742.44M | ---- | ---29.92M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -608.93%-40.98M | ---- | ---5.78M | ---- | ---- | ---- | ---- | ---- | -4,295.00%-839K |
Depreciation and amortization: | ---- | -14.13%30.52M | ---- | 25.86%35.54M | ---- | 1.19%28.24M | ---- | 6.52%27.9M | ---- | 46.04%26.2M |
-Other depreciation and amortization | ---- | -356.64%-2.26M | ---- | 111.78%881K | ---- | -1.48%-7.48M | ---- | 1.79%-7.37M | ---- | -25.27%-7.5M |
Financial expense | ---- | 33.94%663.74M | ---- | 59.62%495.56M | ---- | 12.78%310.47M | ---- | -17.56%275.28M | ---- | 2.40%333.9M |
Special items | ---- | ---- | ---- | ---- | ---- | -14,688.28%-37.86M | ---- | 97.08%-256K | ---- | -60.13%-8.76M |
Operating profit before the change of operating capital | ---- | 170.43%628.2M | ---- | 527.08%232.3M | ---- | 98.61%37.04M | ---- | -98.81%18.65M | ---- | 85.91%1.56B |
Change of operating capital | ||||||||||
Developing property (increase)decrease | -73.55%26.74M | 237.99%828.05M | --101.1M | --244.99M | ---- | ---- | ---- | ---- | ---- | ---- |
Accounts receivable (increase)decrease | 3,674.53%112.78M | 17.51%-21.46M | -84.67%2.99M | -120.89%-26.01M | 168.80%19.49M | 280.83%124.51M | -117.92%-28.33M | -84.13%32.69M | 146.69%158.1M | -55.26%206.03M |
Accounts payable increase (decrease) | 24.21%-62.1M | -72.45%-184.62M | 18.97%-81.94M | -122.74%-107.06M | -107.34%-101.12M | -119.52%-48.06M | -363.01%-48.77M | 587.84%246.18M | -107.00%-10.53M | -26.26%35.79M |
Financial assets at fair value (increase)decrease | -71.94%32.95M | -92.75%8.1M | 22.15%117.42M | -71.11%111.7M | -63.41%96.13M | -48.03%386.66M | 371.70%262.68M | 239.53%744.01M | -147.16%-96.68M | ---533.25M |
Special items for working capital changes | -99.64%2.96M | ---- | --818.73M | ---- | ---- | 17.85%-443.44M | ---- | 39.00%-539.77M | ---- | -764.61%-884.87M |
Cash from business operations | -88.17%113.34M | 104.69%1.14B | 6,513.15%958.31M | 886.29%559.34M | -92.19%14.49M | -88.70%56.71M | 264.70%185.58M | 30.09%501.77M | -87.87%50.89M | -73.98%385.7M |
Other taxs | ---- | -866.68%-20.51M | ---- | 95.05%-2.12M | ---- | -2.14%-42.87M | ---- | -202.67%-41.97M | ---- | 59.14%-13.87M |
Special items of business | -136.38%-25.29M | ---- | 193.19%69.52M | ---- | 104.37%23.71M | ---- | -695.10%-542.41M | ---- | -91.23%91.15M | ---- |
Net cash from operations | -91.43%88.05M | 101.78%1.12B | 2,590.45%1.03B | 3,924.96%557.22M | 110.71%38.2M | -96.99%13.84M | -351.23%-356.82M | 23.66%459.8M | -90.27%142.03M | -74.33%371.84M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -22.47%47.48M | 35.66%168.5M | 28.19%61.25M | 34.51%124.2M | -33.18%47.78M | -51.52%92.34M | -31.96%71.5M | -2.60%190.48M | -31.81%105.09M | -22.69%195.57M |
Dividend received - investment | 457.83%21.92M | 0.92%20.95M | -62.63%3.93M | -24.31%20.76M | -85.07%10.51M | -54.72%27.42M | 91.59%70.42M | -90.29%60.56M | 416.29%36.76M | 65.90%623.52M |
Loan receivable (increase) decrease | 68.63%-121.86M | -1,890.92%-511.15M | -18.89%-388.45M | -91.46%28.54M | -156.90%-326.74M | 115.30%334.2M | 175.86%574.22M | -616.01%-2.18B | -252.29%-757M | 75.86%-305.11M |
Decrease in deposits (increase) | ---- | 37.57%11.7M | ---5.3M | --8.51M | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | ---- | ---- | --700K | ---- | ---- | ---- | ---- | ---- | 13,800.00%4.17M |
Purchase of fixed assets | ---- | 76.47%-4K | ---- | 99.72%-17K | 99.68%-17K | -2,897.51%-6.03M | ---5.25M | 98.87%-201K | ---- | 75.80%-17.85M |
Purchase of intangible assets | ---- | ---- | ---- | ---490K | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of subsidiaries | ---- | ---- | ---- | -79.80%206.58M | ---- | 2,741.96%1.02B | --422.29M | --35.98M | ---- | ---- |
Recovery of cash from investments | 71.54%24.62M | -89.68%14.35M | -91.38%14.35M | 822.57%139.13M | 665.83%166.42M | 3.72%-19.26M | -89.41%21.73M | -183.86%-20M | 624.39%205.24M | 421.79%23.85M |
Cash on investment | 40.61%-130.34M | -290.11%-208.26M | -469.46%-219.46M | 73.46%-53.39M | 35.23%-38.54M | ---201.16M | ---59.5M | ---- | ---- | 100.00%-44K |
Other items in the investment business | ---- | ---- | ---- | ---- | 48.48%-10.89M | -58.39%-41.39M | ---21.14M | -167.03%-26.13M | ---- | -71.79%38.99M |
Net cash from investment operations | 70.36%-158.19M | -206.20%-503.92M | -252.32%-533.68M | -60.74%474.52M | -114.10%-151.48M | 162.18%1.21B | 362.08%1.07B | -445.23%-1.94B | -167.70%-409.91M | 129.19%563.09M |
Net cash before financing | -114.19%-70.14M | -39.86%620.45M | 536.26%494.16M | -15.61%1.03B | -115.79%-113.27M | 182.38%1.22B | 367.83%717.46M | -258.74%-1.48B | -112.97%-267.88M | 294.66%934.93M |
Cash flow from financing activities | ||||||||||
New borrowing | 29.17%2.43B | -47.13%2.26B | -39.22%1.88B | 69.70%4.28B | 47.46%3.1B | -26.17%2.52B | 88.85%2.1B | -48.56%3.41B | 12.29%1.11B | 66.95%6.64B |
Refund | -29.98%-2.66B | 25.46%-2.79B | 9.92%-2.04B | -154.23%-3.74B | -85.13%-2.27B | 42.40%-1.47B | -42.31%-1.22B | 54.93%-2.55B | 45.65%-860.66M | -40.40%-5.67B |
Issuance of bonds | ---- | ---- | ---- | ---- | ---- | --2.34B | --2.34B | ---- | ---- | ---- |
Interest paid - financing | 21.95%-252.68M | -34.44%-660.81M | -66.06%-323.75M | -57.44%-491.51M | -27.09%-194.96M | -5.11%-312.2M | 6.08%-153.4M | 17.62%-297.01M | 3.13%-163.33M | -0.12%-360.54M |
Dividends paid - financing | 98.01%-800K | 0.03%-40.95M | 0.03%-40.15M | -2.06%-40.96M | -1.08%-40.16M | 22.71%-40.13M | 23.48%-39.73M | 26.47%-51.93M | 26.46%-51.93M | 60.66%-70.62M |
Issuance expenses and redemption of securities expenses | ---- | 98.54%-19.17M | 98.60%-18.35M | 40.26%-1.31B | 37.60%-1.31B | -3,285.15%-2.19B | -2,207.07%-2.1B | -151.52%-64.74M | 6.02%-90.94M | -14,525.00%-25.74M |
Other items of the financing business | ---- | ---- | ---- | 51.55%-36.51M | 2.04%-36.51M | 55.15%-75.35M | 16.90%-37.27M | 9.90%-168M | 0.00%-44.85M | -107.88%-186.47M |
Net cash from financing operations | 12.04%-477.41M | 6.99%-1.25B | 27.81%-542.76M | -274.05%-1.34B | -184.80%-751.82M | 176.76%770.17M | 989.03%886.59M | -14.89%278.29M | 89.76%-99.73M | 147.39%326.98M |
Effect of rate | -111.03%-3.1M | ---- | 66.61%28.09M | ---- | 166.20%16.86M | ---- | ---25.47M | ---- | ---- | ---- |
Net Cash | -1,026.57%-547.55M | -102.86%-626.42M | 94.38%-48.6M | -115.50%-308.79M | -153.93%-865.09M | 265.26%1.99B | 536.36%1.6B | -195.56%-1.21B | -133.70%-367.6M | 207.83%1.26B |
Begining period cash | -19.91%2.52B | -8.94%3.15B | -8.94%3.15B | 136.22%3.46B | 136.22%3.46B | -45.18%1.46B | -45.18%1.46B | 89.70%2.67B | 89.70%2.67B | -45.41%1.41B |
Cash at the end | -36.99%1.97B | -19.91%2.52B | 19.90%3.13B | -8.94%3.15B | -14.27%2.61B | 136.22%3.46B | 32.17%3.04B | -45.18%1.46B | -7.86%2.3B | 89.70%2.67B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.